Prostate cancer : improving the therapeutic indexSCHER, H. I.Seminars in oncology. 1994, Vol 21, Num 5, pp 688-693, issn 0093-7754Article

Systemic chemotherapy in regionally advanced bladder cancer : theoretical considerations and resultsSCHER, H. I.Urologic clinics of North America. 1992, Vol 19, Num 4, pp 747-759, issn 0094-0143Article

New approaches to the treatment of bladder cancerSCHER, H. I.The New England journal of medicine. 1993, Vol 329, Num 19, pp 1420-1421, issn 0028-4793Article

Clinical states in prostate cancer : Toward a dynamic model of disease progressionSCHER, H. I; HELLER, G.Urology (Ridgewood, NJ). 2000, Vol 55, Num 3, pp 323-327, issn 0090-4295Article

Primary squamous cell carcinoma of the prostate after radiation seed implantation for adenocarcinomaMILLER, V. A; REUTER, V; SCHER, H. I et al.Urology (Ridgewood, NJ). 1995, Vol 46, Num 1, pp 111-113, issn 0090-4295Article

Transrectal sonography for serial evaluation of prostatic malignancyDERSHAW, D. D; SCHER, H. I; SMART, T et al.Urology (Ridgewood, NJ). 1990, Vol 36, Num 2, pp 172-176, issn 0090-4295, 5 p.Article

Clinical trials in relapsed prostate cancer : Defining the targetSCHER, H. I; MAZUMDAR, M; KELLY, W. K et al.Journal of the National Cancer Institute. 1996, Vol 88, Num 22, pp 1623-1634, issn 0027-8874Article

Flutamide withdrawal syndrome : its impact on clinical trials in hormone-refractory prostate cancerSCHER, H. I; KELLY, W. K.Journal of clinical oncology. 1993, Vol 11, Num 8, pp 1566-1572, issn 0732-183XArticle

Acute arterial thrombosis after escalated-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony-stimulating factor : a possible new recombinant granulocyte colony-stimulating factor toxicityCONTI, J. A; SCHER, H. I.Cancer. 1992, Vol 70, Num 11, pp 2699-2702, issn 0008-543XArticle

Chemotherapy for muscle-infiltrating bladder cancerSCHER, H. I; KANTOFF, P. W.Hematology/oncology clinics of North America. 1992, Vol 6, Num 1, pp 169-178, issn 0889-8588Article

Chemotherapy for metastatic bladder cancerKANTOFF, P. W; SCHER, H. I.Hematology/oncology clinics of North America. 1992, Vol 6, Num 1, pp 195-203, issn 0889-8588Article

Steroid hormone withdrawal syndromes : Pathophysiology and clinical significance : Prostate-specific antigen: the best prostatic tumor markerKELLY, W. K; SLOVIN, S; SCHER, H. I et al.Urologic clinics of North America. 1997, Vol 24, Num 2, issn 0094-0143, xiv,421-431 [12 p.]Article

Serial transabsominal sonography of bladder cancerDERSHAW, D. D; SCHER, H. I.American journal of roentgenology (1976). 1988, Vol 150, Num 5, pp 1055-1059, issn 0361-803XArticle

Advances in the treatment of urothelial tract tumorsSTERNBERG, C. N; SCHER, H. I.Urologic clinics of North America. 1987, Vol 14, Num 2, pp 373-387, issn 0094-0143Article

Interstitial pneumonitis following bicalutamide treatment for prostate cancerMCCAFFREY, J. A; SCHER, H. I.The Journal of urology. 1998, Vol 160, Num 1, issn 0022-5347, p. 131Article

Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancerHERR, H. W; SCHER, H. I.Journal of clinical oncology. 1994, Vol 12, Num 5, pp 975-980, issn 0732-183XArticle

The phase II/III transition : Toward the proof of efficacy in cancer clinical trialsFAZZARI, M; HELLER, G; SCHER, H. I et al.Controlled clinical trials. 2000, Vol 21, Num 4, pp 360-368, issn 0197-2456Article

Hormone-refractory (D3) prostate cancer : refining the conceptSCHER, H. I; STEINECK, G; KELLY, W. K et al.Urology (Ridgewood, NJ). 1995, Vol 46, Num 2, pp 142-148, issn 0090-4295Article

Bone metastases : improving the therapeutic indexSCHER, H. I; CHUNG, L. W. K.Seminars in oncology. 1994, Vol 21, Num 5, pp 630-656, issn 0093-7754Article

Prostate specific antigen decline after antiandrogen withdrawal : the flutamide withdrawal syndromeKELLEY, W. K; SCHER, H. I.The Journal of urology. 1993, Vol 149, Num 3, pp 607-609, issn 0022-5347Article

The evolving role of chemotherapy for muscle infiltrating bladder cancerSEIDMAN, A. D; SCHER, H. I.Seminars in oncology. 1991, Vol 18, Num 6, pp 585-595, issn 0093-7754Article

Supportive care is not the only option in prostate cancer patients resistant to hormone therapy : The argument forSCHER, H. I.European urology. 1996, Vol 29, pp 40-44, issn 0302-2838, SUP2Conference Paper

Sonography in evaluation of carcinoma of bladderDERSHAW, D. D; SCHER, H. I.Urology (Ridgewood, NJ). 1987, Vol 29, Num 4, pp 454-457, issn 0090-4295Article

Peptide and carbohydrate vaccines in relapsed prostate cancer : Immunogenicity of synthetic vaccines in man : Clinical trials at memorial sloan-kettering cancer centerSLOVIN, S. F; SCHER, H. I.Seminars in oncology. 1999, Vol 26, Num 4, pp 448-454, issn 0093-7754Article

Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer : Ten-year outcomeHERR, H. W; BAJORIN, D. F; SCHER, H. I et al.Journal of clinical oncology. 1998, Vol 16, Num 4, pp 1298-1301, issn 0732-183XArticle